Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA)
Stopped Sponsor has decided to withdraw the study due to safety issue and re-initiate with a new clinical study
Conditions
Interventions
- DRUG: KM-819
- DRUG: Placebo
Sponsor
Kainos Medicine Inc.
Collaborators